Identification of ALK as a major familial neuroblastoma predisposition gene

…, R Sennett, JE Lynch, P Perri, G Laureys… - Nature, 2008 - nature.com
Neuroblastoma is a childhood cancer that can be inherited, but the genetic aetiology is largely
unknown. Here we show that germline mutations in the anaplastic lymphoma kinase (ALK…

[HTML][HTML] Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma

…, J Bökkerink, M Egeler, G Laureys… - … England Journal of …, 1996 - Mass Medical Soc
Background Neuroblastoma is a childhood tumor derived from cells of the neural crest, with
a widely variable outcome. Differences in the behavior and prognosis of the tumor suggest …

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

…, T Van Maerken, A De Paepe, G Laureys… - Clinical cancer …, 2010 - AACR
Purpose: Activating mutations of the anaplastic lymphoma kinase (ALK) were recently
described in neuroblastoma. We carried out a meta-analysis of 709 neuroblastoma tumors to …

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international …

…, V Castel, I Yaniv, V Papadakis, G Laureys… - The lancet …, 2017 - thelancet.com
Background High-dose chemotherapy with haemopoietic stem-cell rescue improves event-free
survival in patients with high-risk neuroblastoma; however, which regimen has the …

[HTML][HTML] Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes

…, Y Benoit, M Renard, AD Paepe, G Laureys… - Genome biology, 2006 - Springer
Background Neuroblastoma tumor cells are assumed to originate from primitive neuroblasts
giving rise to the sympathetic nervous system. Because these precursor cells are not …

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

…, S De Bie, A De Paepe, G Laureys… - Journal of Clinical …, 2005 - ascopubs.org
Purpose Neuroblastoma is a genetically heterogeneous pediatric tumor with a remarkably
variable clinical behavior ranging from widely disseminated disease to spontaneous …

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

…, P McGrady, WB London, G Laureys… - The lancet …, 2009 - thelancet.com
Background More accurate prognostic assessment of patients with neuroblastoma is required
to better inform the choice of risk-related therapy. The aim of this study is to develop and …

[HTML][HTML] Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay

…, F Speleman, V Combaret, J Lunec, G Laureys… - Modern …, 2002 - nature.com
Amplification of the proto-oncogene MYCN is a strong adverse prognostic factor in neuroblastoma
patients in all tumor stages. The status of the MYCN gene has become an important …

Randomized trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European …

…, P Brock, I Yaniv, V Castel, G Laureys… - Journal of Clinical …, 2010 - ascopubs.org
Purpose To reduce the incidence of febrile neutropenia during rapid COJEC (cisplatin,
vincristine, carboplatin, etoposide, and cyclophosphamide given in a rapid delivery schedule) …

The expression and role of CXC chemokines in colorectal cancer

H Verbeke, S Struyf, G Laureys… - Cytokine & growth factor …, 2011 - Elsevier
Cancer is a life-threatening disease world-wide and colorectal cancer is the second common
cause of cancer mortality. The interaction between tumor cells and stromal cells plays a …